Capecitabine in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
PHASE2CompletedINTERVENTIONAL
Timeline
Start Date
March 31, 2000
Primary Completion Date
June 30, 2001
Study Completion Date
June 30, 2001
Conditions
Prostate Cancer
Interventions
DRUG
capecitabine
Trial Locations (2)
CH-2500
Spitalzentrum Biel, Biel
CH-9007
Kantonsspital - Saint Gallen, Sankt Gallen
All Listed Sponsors
lead
Swiss Cancer Institute
OTHER
NCT00006023 - Capecitabine in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | Biotech Hunter | Biotech Hunter